Keyphrases
All-oral Regimen
18%
Ambient Ozone
18%
Amikacin
23%
Black Residents
18%
Chronic Obstructive Pulmonary Disease
100%
Chronic Obstructive Pulmonary Disease Assessment Test
19%
Clofazimine
23%
Confidence Interval
25%
Current Smokers
20%
Disease Morbidity
38%
Docosahexaenoic Acid
15%
Eicosapentaenoic Acid
18%
Exacerbation Risk
28%
FEV1 Decline
18%
Food Insecurity
18%
Former Smokers
29%
Health-related Quality of Life
18%
Imipenem
29%
Indoor Air Pollution
19%
Indoor Particulate Matter
18%
Linezolid
29%
Lung Disease
26%
Lung Function
16%
Lung Function Decline
18%
Mouse Model
39%
Mycobacterium Abscessus
33%
Mycobacterium Avium Complex Pulmonary Disease
18%
Mycobacteroides Abscessus
37%
Neighborhood Deprivation
21%
Neighborhood Factors
18%
Omadacycline
54%
Omega-3
18%
Ozone Effect
18%
Patient-reported Health
18%
Patient-reported Symptoms
18%
Perceived Stress
18%
Phthalates
18%
Pollution Function
18%
Racial Disparities
18%
Racial Segregation
18%
Respiratory Morbidity
20%
Respiratory Outcomes
55%
Respiratory Symptoms
23%
Severe Exacerbations
19%
Smokers
18%
Socioeconomic Status
16%
Specific Quality of Life
19%
SPIROMICS
36%
Three-drug Regimen
18%
Three-level
18%
Medicine and Dentistry
Adverse Event
6%
Air Trapping
8%
Atmospheric Aerosol
36%
Biological Marker
18%
Body Mass Index
6%
Bronchiectasis
7%
Chronic Obstructive Pulmonary Disease
94%
Cohort Analysis
6%
Computer Assisted Tomography
6%
Disease Assessment
8%
Docosahexaenoic Acid
15%
Dyspnea
14%
Emphysema
8%
Forced Expiratory Volume
6%
Health Outcomes
10%
Icosapentaenoic Acid
18%
Lung
18%
Medical Research
14%
Mixed Model
8%
Mycobacterium Avium Complex
18%
Omega-3 Fatty Acid
18%
Particular Matter 2.5
6%
Psychometry
5%
Quality of Life
40%
Racial Disparity
18%
Respiratory Physiology
12%
Respiratory System Disease
6%
Silo-Filler's Disease
18%
Six Minute Walk Test
8%
Smoking
60%
Socioeconomic Status
19%
Spirometry
5%
St. George Respiratory Questionnaire
8%
Symptom
30%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
20%
Antibiotic Agent
6%
Biapenem
5%
Biological Marker
20%
Bronchiectasis
9%
Cefoxitin
5%
Chronic Obstructive Lung Disease
92%
Clofazimine
20%
Disease
27%
Disease Exacerbation
9%
Dyspnea
5%
Imipenem
23%
Infection
5%
Linezolid
23%
Lung Disease
41%
Mixed Model
10%
Mouse Model
36%
Mycobacterium Avium Complex
18%
Nitrogen Dioxide
9%
Omadacycline
36%
Phthalic Acid
18%
Rifabutin
5%
Symptom
19%